Rexahn Pharma (RNN) Announces Receipt of U.S. Patent Related to RX-21101
Tweet Send to a Friend
Rexahn Pharmaceuticals, Inc. (NYSE: RNN) announced that it has been issued a patent from the United States Patent and Trademark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE